We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Guidance on ‘Fit-for-Purpose’ Clinical Outcome Assessments
FDA Releases Guidance on ‘Fit-for-Purpose’ Clinical Outcome Assessments
In its latest guidance on patient-focused drug development, released yesterday, the FDA calls for high-quality clinical outcome assessments (COAs) for drug trials.
